(Hypertension. 1996;27:1205-1209.)
© 1996 American Heart Association, Inc.
Articles |
From the Department of Geriatric Medicine, Osaka (Japan) University Medical School (Y.N., T.K., H.R., S.T., M.O., K.K., J.H., T.M., T.O.), and the Japan Research Foundation for Chronic Diseases and Rehabilitation Affiliated Hospital, Sakuragaoka Hospitel (Y.T., Y.K.), Hyogo, Japan.
Abstract The apolipoprotein
4 allele and homozygous
deletion allele (DD) of the
angiotensin-converting enzyme gene are reported to be
associated with an increase in the incidence of ischemic heart
disease. In this study, we examined whether the apolipoprotein
4
genotype and angiotensin-converting
enzyme/DD allele are associated with silent myocardial
ischemia. We screened 3920 subjects undergoing general checkups
who had no symptoms of ischemic heart disease. Seventy subjects
(2%) showed ischemic ST-segment depression during the double
two-step exercise test. One hundred and twenty control subjects
without ischemic ST-segment depression were recruited from the
same population and matched for sex, age, and blood pressure. We
performed genotyping of the apolipoprotein E gene (
2,
3, and
4) and angiotensin-converting enzyme gene
(I and D) using polymerase chain
reactionrestriction fragment length polymorphism and
polymerase chain reaction, respectively. Allele frequency of
4
of the apolipoprotein E gene was higher in the ischemic group
(11%) than the nonischemic group (5%)
(
2=5.35, P<.05), but there was no
significant association between the allele or the genotype
frequency of the angiotensin-converting enzyme gene and
the incidence of ischemic ST-segment depression. Furthermore,
stepwise multiple regression analysis also revealed that total
cholesterol level and
4 genotype were predictors
of ischemic change in the exercise tolerance test
(
2=12.8, P<.005,
R2=.051). These results suggest that the
apolipoprotein
4 allele is an independent genetic risk factor
for silent myocardial ischemia in Japanese subjects.
Key Words: polymorphism genetics apolipoprotein E angiotensin-converting enzyme myocardial ischemia
This article has been cited by other articles:
![]() |
E. Zintzaras, G. Raman, G. Kitsios, and J. Lau Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphic Variant as a Marker of Coronary Artery Disease: A Meta-analysis Arch Intern Med, May 26, 2008; 168(10): 1077 - 1089. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Song, M. J. Stampfer, and S. Liu Meta-Analysis: Apolipoprotein E Genotypes and Risk for Coronary Heart Disease Ann Intern Med, July 20, 2004; 141(2): 137 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Bernstein, M. C. Costanza, R. W. James, M. A. Morris, F. Cambien, S. Raoux, and A. Morabia Physical Activity May Modulate Effects of ApoE Genotype on Lipid Profile Arterioscler. Thromb. Vasc. Biol., January 1, 2002; 22(1): 133 - 140. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |